OK
Oklahoma House Bill HB2091

Oklahoma 2023 Regular Session

Oklahoma House Bill HB2091 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11
22
33 Req. No. 6082 Page 1 1
44 2
55 3
66 4
77 5
88 6
99 7
1010 8
1111 9
1212 10
1313 11
1414 12
1515 13
1616 14
1717 15
1818 16
1919 17
2020 18
2121 19
2222 20
2323 21
2424 22
2525 23
2626 24
2727
2828 STATE OF OKLAHOMA
2929
3030 1st Session of the 59th Legislature (2023)
3131
3232 HOUSE BILL 2091 By: Echols
3333
3434
3535
3636
3737
3838 AS INTRODUCED
3939
4040 An Act relating to public health and safety; amending
4141 63 O.S. 2021, Section 2 -101, as amended by Section 4,
4242 Chapter 265, O.S.L. 2022 (63 O.S. Supp. 2022, Section
4343 2-101), which relates to the Uniform Controlled
4444 Dangerous Substances Act; decriminalizing certain
4545 drug testing strips; and providing an effective date.
4646
4747
4848
4949
5050
5151
5252 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
5353 SECTION 1. AMENDATORY 63 O.S. 2021, Section 2 -101, as
5454 amended by Section 4, Chapter 265, O.S.L. 2022 (63 O. S. Supp. 2022,
5555 Section 2-101), is amended to read as follows:
5656 Section 2-101. 1. "Administer" means the direct application of
5757 a controlled dangerous substance, whether by injection, inhalation,
5858 ingestion or any other means, to the body of a patient, animal or
5959 research subject by:
6060 a. a practitioner (or, in the presence of the
6161 practitioner, by the authorized agent of the
6262 practitioner), or
6363
6464 Req. No. 6082 Page 2 1
6565 2
6666 3
6767 4
6868 5
6969 6
7070 7
7171 8
7272 9
7373 10
7474 11
7575 12
7676 13
7777 14
7878 15
7979 16
8080 17
8181 18
8282 19
8383 20
8484 21
8585 22
8686 23
8787 24
8888
8989 b. the patient or research subject at the direction and
9090 in the presence of the practitioner;
9191 2. "Agent" means a peace officer appointed by and who acts on
9292 behalf of the Director of the Oklahoma State Bureau of Narcotics and
9393 Dangerous Drugs Control or an authorized person who acts on behalf
9494 of or at the direction of a person who manufactures, distrib utes,
9595 dispenses, prescribes, administers or uses for scientific purposes
9696 controlled dangerous substances but does not include a common or
9797 contract carrier, public warehouser or employee thereof, or a person
9898 required to register under the Uniform Controlled Dangerous
9999 Substances Act;
100100 3. "Board" means the Advisory Board to the Director of the
101101 Oklahoma State Bureau of Narcotics and Dangerous Drugs Control;
102102 4. "Bureau" means the Oklahoma State Bureau of Narcotics and
103103 Dangerous Drugs Control;
104104 5. "Coca leaves" includes cocaine and any compound,
105105 manufacture, salt, derivative, mixture or preparation of coca
106106 leaves, except derivatives of coca leaves which do not contain
107107 cocaine or ecgonine;
108108 6. "Commissioner" or "Director" means the Director of the
109109 Oklahoma State Bureau of Narcotics and Dangerous Drugs Control;
110110 7. "Control" means to add, remove or change the placement of a
111111 drug, substance or immediate precursor under the Uniform Controlled
112112 Dangerous Substances Act;
113113
114114 Req. No. 6082 Page 3 1
115115 2
116116 3
117117 4
118118 5
119119 6
120120 7
121121 8
122122 9
123123 10
124124 11
125125 12
126126 13
127127 14
128128 15
129129 16
130130 17
131131 18
132132 19
133133 20
134134 21
135135 22
136136 23
137137 24
138138
139139 8. "Controlled dangerous substance" means a drug, substance or
140140 immediate precursor in Schedules I through V of the Uniform
141141 Controlled Dangerous Substances Act or any drug, substance or
142142 immediate precursor listed either temporarily or permanently as a
143143 federally controlled substance. Any conflict between state and
144144 federal law with regard to the particular schedule in which a
145145 substance is listed shall be resolved in favor of state law;
146146 9. "Counterfeit substance" means a controlled substance which,
147147 or the container or labeling of which without authorization , bears
148148 the trademark, trade name or other identifying marks, imprint,
149149 number or device or any likeness thereof of a manufacturer,
150150 distributor or dispenser other than the person who in fact
151151 manufactured, distributed or dispensed the substance;
152152 10. "Deliver" or "delivery" means the actual, constructive or
153153 attempted transfer from one person to another of a controlled
154154 dangerous substance or drug paraphernalia, whether or not there is
155155 an agency relationship;
156156 11. "Dispense" means to deliver a controlled danger ous
157157 substance to an ultimate user or human research subject by or
158158 pursuant to the lawful order of a practitioner, including the
159159 prescribing, administering, packaging, labeling or compounding
160160 necessary to prepare the substance for such distribution .
161161 "Dispenser" is a practitioner who delivers a controlled dangerous
162162 substance to an ultimate user or human research subject;
163163
164164 Req. No. 6082 Page 4 1
165165 2
166166 3
167167 4
168168 5
169169 6
170170 7
171171 8
172172 9
173173 10
174174 11
175175 12
176176 13
177177 14
178178 15
179179 16
180180 17
181181 18
182182 19
183183 20
184184 21
185185 22
186186 23
187187 24
188188
189189 12. "Distribute" means to deliver other than by administering
190190 or dispensing a controlled dangerous substance;
191191 13. "Distributor" means a commercial entity engaged in the
192192 distribution or reverse distribution of narcotics and dangerous
193193 drugs and who complies with all regulations promulgated by the
194194 federal Drug Enforcement Administration and the Oklahoma State
195195 Bureau of Narcotics and Dangerous Drugs Control;
196196 14. "Drug" means articles:
197197 a. recognized in the official United States Pharmacopeia,
198198 official Homeopathic Pharmacopoeia of the United
199199 States, or official National Formulary, or any
200200 supplement to any of them,
201201 b. intended for use in the diagn osis, cure, mitigation,
202202 treatment or prevention of disease in man or other
203203 animals,
204204 c. other than food, intended to affect the structure or
205205 any function of the body of man or other animals, and
206206 d. intended for use as a component of any article
207207 specified in this paragraph;
208208 provided, however, the term "drug" does not include devices or their
209209 components, parts or accessories;
210210 15. "Drug-dependent person" means a person who is using a
211211 controlled dangerous substance and who is in a state of psychic or
212212 physical dependence, or both, arising from administration of that
213213
214214 Req. No. 6082 Page 5 1
215215 2
216216 3
217217 4
218218 5
219219 6
220220 7
221221 8
222222 9
223223 10
224224 11
225225 12
226226 13
227227 14
228228 15
229229 16
230230 17
231231 18
232232 19
233233 20
234234 21
235235 22
236236 23
237237 24
238238
239239 controlled dangerous substance on a continuous basis. Drug
240240 dependence is characterized by behavioral and other responses which
241241 include a strong compulsion to take the substance on a continuous
242242 basis in order to experience its psychic effects, or to avoid the
243243 discomfort of its absence;
244244 16. "Home care agency" means any sole proprietorship,
245245 partnership, association, corporation, or other organization which
246246 administers, offers, or provides home care serv ices, for a fee or
247247 pursuant to a contract for such services, to clients in their place
248248 of residence;
249249 17. "Home care services" means skilled or personal care
250250 services provided to clients in their place of residence for a fee;
251251 18. "Hospice" means a centrally administered, nonprofit or for-
252252 profit, medically directed, nurse-coordinated program which provides
253253 a continuum of home and inpatient care for the terminally ill
254254 patient and the patient's family. Such term shall also include a
255255 centrally administered, n onprofit or for-profit, medically directed,
256256 nurse-coordinated program if such program is licensed pursuant to
257257 the provisions of the Uniform Controlled Dangerous Substances Act.
258258 A hospice program offers palliative and supportive care to meet the
259259 special needs arising out of the physical, emotional and spiritual
260260 stresses which are experienced during the final stages of illness
261261 and during dying and bereavement. This care is available twenty-
262262 four (24) hours a day, seven (7) days a week, and is provided on the
263263
264264 Req. No. 6082 Page 6 1
265265 2
266266 3
267267 4
268268 5
269269 6
270270 7
271271 8
272272 9
273273 10
274274 11
275275 12
276276 13
277277 14
278278 15
279279 16
280280 17
281281 18
282282 19
283283 20
284284 21
285285 22
286286 23
287287 24
288288
289289 basis of need, regardless of ability to pay. "Class A" Hospice
290290 refers to Medicare-certified hospices. "Class B" refers to all
291291 other providers of hospice services;
292292 19. "Imitation controlled substance" means a substance that is
293293 not a controlled dangerous substance, which by dosage unit
294294 appearance, color, shape, size, markings or by representations made,
295295 would lead a reasonable person to believe that the substance is a
296296 controlled dangerous substance. In the event the appearance of the
297297 dosage unit is not r easonably sufficient to establish that the
298298 substance is an "imitation controlled substance", the court or
299299 authority concerned should consider, in addition to all other
300300 factors, the following factors as related to "representations made"
301301 in determining wheth er the substance is an "imitation controlled
302302 substance":
303303 a. statements made by an owner or by any other person in
304304 control of the substance concerning the nature of the
305305 substance, or its use or effect,
306306 b. statements made to the recipient that the substance
307307 may be resold for inordinate profit,
308308 c. whether the substance is packaged in a manner normally
309309 used for illicit controlled substances,
310310 d. evasive tactics or actions utilized by the owner or
311311 person in control of the substance to avoid detection
312312 by law enforcement authorities,
313313
314314 Req. No. 6082 Page 7 1
315315 2
316316 3
317317 4
318318 5
319319 6
320320 7
321321 8
322322 9
323323 10
324324 11
325325 12
326326 13
327327 14
328328 15
329329 16
330330 17
331331 18
332332 19
333333 20
334334 21
335335 22
336336 23
337337 24
338338
339339 e. prior convictions, if any, of an owner, or any other
340340 person in control of the object, under state or
341341 federal law related to controlled substances or fraud,
342342 and
343343 f. the proximity of the substances to controlled
344344 dangerous substances;
345345 20. "Immediate precursor" means a substance which the Director
346346 has found to be and by regulation designates as being the principal
347347 compound commonly used or produced primarily for use, and which is
348348 an immediate chemical intermediary used, or likely to be us ed, in
349349 the manufacture of a controlled dangerous substance, the control of
350350 which is necessary to prevent, curtail or limit such manufacture;
351351 21. "Laboratory" means a laboratory approved by the Director as
352352 proper to be entrusted with the custody of control led dangerous
353353 substances and the use of controlled dangerous substances for
354354 scientific and medical purposes and for purposes of instruction;
355355 22. "Manufacture" means the production, preparation,
356356 propagation, compounding or processing of a controlled danger ous
357357 substance, either directly or indirectly by extraction from
358358 substances of natural or synthetic origin, or independently by means
359359 of chemical synthesis or by a combination of extraction and chemical
360360 synthesis. "Manufacturer" includes any person who pac kages,
361361 repackages or labels any container of any controlled dangerous
362362
363363 Req. No. 6082 Page 8 1
364364 2
365365 3
366366 4
367367 5
368368 6
369369 7
370370 8
371371 9
372372 10
373373 11
374374 12
375375 13
376376 14
377377 15
378378 16
379379 17
380380 18
381381 19
382382 20
383383 21
384384 22
385385 23
386386 24
387387
388388 substance, except practitioners who dispense or compound
389389 prescription orders for delivery to the ultimate consumer;
390390 23. "Marijuana" means all parts of the plant Cannabis sativa
391391 L., whether growing or not; the seeds thereof; the resin extracted
392392 from any part of such plant; and every compound, manufacture, salt,
393393 derivative, mixture or preparation of such plant, its seeds or
394394 resin, but shall not include:
395395 a. the mature stalks of such plant o r fiber produced from
396396 such stalks,
397397 b. oil or cake made from the seeds of such plant,
398398 including cannabidiol derived from the seeds of the
399399 marijuana plant,
400400 c. any other compound, manufacture, salt, derivative,
401401 mixture or preparation of such mature stalks (ex cept
402402 the resin extracted therefrom), including cannabidiol
403403 derived from mature stalks, fiber, oil or cake,
404404 d. the sterilized seed of such plant which is incapable
405405 of germination,
406406 e. for any person participating in a clinical trial to
407407 administer cannabidiol for the treatment of severe
408408 forms of epilepsy pursuant to Section 2-802 of this
409409 title, a drug or substance approved by the federal
410410 Food and Drug Administration for use by those
411411 participants,
412412
413413 Req. No. 6082 Page 9 1
414414 2
415415 3
416416 4
417417 5
418418 6
419419 7
420420 8
421421 9
422422 10
423423 11
424424 12
425425 13
426426 14
427427 15
428428 16
429429 17
430430 18
431431 19
432432 20
433433 21
434434 22
435435 23
436436 24
437437
438438 f. for any person or the parents, legal guardians or
439439 caretakers of the person who have received a written
440440 certification from a physician licensed in this state
441441 that the person has been diagnosed by a physician as
442442 having Lennox-Gastaut syndrome, Dravet syndrome, also
443443 known as severe myoclonic epilepsy of infancy, or any
444444 other severe form of epilepsy that is not adequately
445445 treated by traditional medical therapies, spasticity
446446 due to multiple sclerosis or due to paraplegia,
447447 intractable nausea and vomiting, appetite stimulation
448448 with chronic wasting diseases, the substance
449449 cannabidiol, a nonpsychoactive cannabinoid, found in
450450 the plant Cannabis sativa L. or any other preparation
451451 thereof, that has a tetrahydrocannabinol concentration
452452 of not more than three-tenths of one percent (0.3%)
453453 and that is delivered to the patient in the form of a
454454 liquid,
455455 g. any federal Food-and-Drug-Administration-approved drug
456456 or substance, or
457457 h. industrial hemp, from the plant Cannabis sativa L. and
458458 any part of such plant, whether growing or not, with a
459459 delta-9 tetrahydrocannabinol concentration of not more
460460 than three-tenths of one percent (0.3%) on a dry-
461461 weight basis which shall only be grown pursuant to the
462462
463463 Req. No. 6082 Page 10 1
464464 2
465465 3
466466 4
467467 5
468468 6
469469 7
470470 8
471471 9
472472 10
473473 11
474474 12
475475 13
476476 14
477477 15
478478 16
479479 17
480480 18
481481 19
482482 20
483483 21
484484 22
485485 23
486486 24
487487
488488 Oklahoma Industrial Hemp Program and may be shipped
489489 intrastate and interstate;
490490 24. "Medical purpose" means an intention to utilize a
491491 controlled dangerous substance for physical or mental treatment, for
492492 diagnosis, or for the prevention of a disease condition not in
493493 violation of any state or federal law and not for the purpose of
494494 satisfying physiological or psychological dependence or other abuse;
495495 25. "Mid-level practitioner" means an Advanced Practice
496496 Registered Nurse as defined and within parameters specified in
497497 Section 567.3a of Title 59 of the Oklahoma Statutes, or a certified
498498 animal euthanasia technician as defined in Section 698.2 of Title 59
499499 of the Oklahoma Statutes, or an animal control officer registered by
500500 the Oklahoma State Bureau of Narcotics and Dangerous Drugs Control
501501 under subsection B of Section 2-301 of this title within the
502502 parameters of such officer's duties under Sections 501 throug h 508
503503 of Title 4 of the Oklahoma Statutes;
504504 26. "Narcotic drug" means any of the following, whether
505505 produced directly or indirectly by extraction from substances of
506506 vegetable origin, or independently by means of chemical synthesis,
507507 or by a combination of e xtraction and chemical synthesis:
508508 a. opium, coca leaves and opiates,
509509 b. a compound, manufacture, salt, derivative or
510510 preparation of opium, coca leaves or opiates,
511511
512512 Req. No. 6082 Page 11 1
513513 2
514514 3
515515 4
516516 5
517517 6
518518 7
519519 8
520520 9
521521 10
522522 11
523523 12
524524 13
525525 14
526526 15
527527 16
528528 17
529529 18
530530 19
531531 20
532532 21
533533 22
534534 23
535535 24
536536
537537 c. cocaine, its salts, optical and g eometric isomers, and
538538 salts of isomers,
539539 d. ecgonine, its derivatives, their salts, isomers and
540540 salts of isomers, and
541541 e. a substance, and any compound, manufacture, salt,
542542 derivative or preparation thereof, which is chemically
543543 identical with any of the subst ances referred to in
544544 subparagraphs a through d of this pa ragraph, except
545545 that the words "narcotic drug" as used in Section 2-
546546 101 et seq. of this title shall not include
547547 decocainized coca leaves or extracts of coca leaves,
548548 which extracts do not contain coca ine or ecgonine;
549549 27. "Opiate" or "opioid" means any Schedule II, III, IV or V
550550 substance having an addiction-forming or addiction-sustaining
551551 liability similar to morphine or being capable of conversion into a
552552 drug having such addiction-forming or addiction -sustaining
553553 liability. The terms do not include, unless specifically designated
554554 as controlled under the Uniform Controlled Dangerous Substances Act,
555555 the dextrorotatory isomer of 3-methoxy-n-methyl-morphinan and its
556556 salts (dextromethorphan). The terms do include the racemic and
557557 levorotatory forms;
558558 28. "Opium poppy" means the plant of the species Papaver
559559 somniferum L., except the seeds thereof;
560560
561561 Req. No. 6082 Page 12 1
562562 2
563563 3
564564 4
565565 5
566566 6
567567 7
568568 8
569569 9
570570 10
571571 11
572572 12
573573 13
574574 14
575575 15
576576 16
577577 17
578578 18
579579 19
580580 20
581581 21
582582 22
583583 23
584584 24
585585
586586 29. "Peace officer" means a police officer, sheriff, deputy
587587 sheriff, district attorney's investigator, investiga tor from the
588588 Office of the Attorney General, or any other person elected or
589589 appointed by law to enforce any of the criminal laws of this state
590590 or of the United States;
591591 30. "Person" means an individual, corporation, government or
592592 governmental subdivision o r agency, business trust, estate, trust,
593593 partnership or association, or any other legal entity;
594594 31. "Poppy straw" means all parts, except the seeds, of the
595595 opium poppy, after mowing;
596596 32. "Practitioner" means:
597597 a. (1) a medical doctor or osteopathic physic ian,
598598 (2) a dentist,
599599 (3) a podiatrist,
600600 (4) an optometrist,
601601 (5) a veterinarian,
602602 (6) a physician assistant or Advanced Practice
603603 Registered Nurse under the supervision of a
604604 licensed medical doctor or osteopathic physician,
605605 (7) a scientific investigator, or
606606 (8) any other person,
607607 licensed, registered or ot herwise permitted to
608608 prescribe, distribute, dispense, conduct research with
609609 respect to, use for scientific purposes or administer
610610
611611 Req. No. 6082 Page 13 1
612612 2
613613 3
614614 4
615615 5
616616 6
617617 7
618618 8
619619 9
620620 10
621621 11
622622 12
623623 13
624624 14
625625 15
626626 16
627627 17
628628 18
629629 19
630630 20
631631 21
632632 22
633633 23
634634 24
635635
636636 a controlled dangerous substance in the course of
637637 professional practice or resear ch in this state, or
638638 b. a pharmacy, hospital , laboratory or other institution
639639 licensed, registered or otherwise permitted to
640640 distribute, dispense, conduct research with respect
641641 to, use for scientific purposes or administer a
642642 controlled dangerous substance in the course of
643643 professional practice or re search in this state;
644644 33. "Production" includes the manufacture, planting,
645645 cultivation, growing or harvesting of a controlled dangerous
646646 substance;
647647 34. "State" means the State of Oklahoma or any other state of
648648 the United States;
649649 35. "Ultimate user" means a person who lawfully possesses a
650650 controlled dangerous substance for the person's own use or for the
651651 use of a member of the person's household or for administration to
652652 an animal owned by the person or by a membe r of the person's
653653 household;
654654 36. "Drug paraphernalia" means all equipment, products and
655655 materials of any kind which are used, intended for use, or fashioned
656656 specifically for use in planting, propagating, cultivating, growing,
657657 harvesting, manufacturing, co mpounding, converting, producing,
658658 processing, preparing, testing, analyzing, packaging, repackaging,
659659 storing, containing, concealing, injecting, ingesting, inhaling or
660660
661661 Req. No. 6082 Page 14 1
662662 2
663663 3
664664 4
665665 5
666666 6
667667 7
668668 8
669669 9
670670 10
671671 11
672672 12
673673 13
674674 14
675675 15
676676 16
677677 17
678678 18
679679 19
680680 20
681681 21
682682 22
683683 23
684684 24
685685
686686 otherwise introducing into the human body, a controlled dangerous
687687 substance in violation of the Uniform Controlled Dangerous
688688 Substances Act including, but not limited to:
689689 a. kits used, intended for use, or fashioned specifically
690690 for use in planting, propagating, cultivating, growing
691691 or harvesting of any species of plant which is a
692692 controlled dangerous substance or from which a
693693 controlled dangerous substance can be derived,
694694 b. kits used, intended for use, or fashioned specifically
695695 for use in manufacturing, compounding, converting,
696696 producing, processing or preparing controlled
697697 dangerous substances,
698698 c. isomerization devices used, intended for use, or
699699 fashioned specifically for use in increasing the
700700 potency of any species of plant which is a controlled
701701 dangerous substance,
702702 d. testing equipment used, intended for use, or fashioned
703703 specifically for use in identifying, or in analyzing
704704 the strength, effectiveness or purity of controlled
705705 dangerous substances,
706706 e. scales and balances used, intended for use, or
707707 fashioned specifically for use in weighing or
708708 measuring controlled dangerous substances,
709709
710710 Req. No. 6082 Page 15 1
711711 2
712712 3
713713 4
714714 5
715715 6
716716 7
717717 8
718718 9
719719 10
720720 11
721721 12
722722 13
723723 14
724724 15
725725 16
726726 17
727727 18
728728 19
729729 20
730730 21
731731 22
732732 23
733733 24
734734
735735 f. diluents and adulterants, such as quinine
736736 hydrochloride, mannitol, mannite, dextrose and
737737 lactose, used, intended for use, or fashioned
738738 specifically for use in cutting controlled dangerous
739739 substances,
740740 g. separation gins and sifters used, intended for use, or
741741 fashioned specifically for use in removing twigs and
742742 seeds from, or in otherwise cleaning or refining,
743743 marijuana,
744744 h. blenders, bowls, containers, spoons and mixing devices
745745 used, intended for use, or fashioned specifically for
746746 use in compounding controlled dan gerous substances,
747747 i. capsules, balloons, envelopes and o ther containers
748748 used, intended for use, or fashioned specifically for
749749 use in packaging small quantities of controlled
750750 dangerous substances,
751751 j. containers and other objects used, intended for use,
752752 or fashioned specifically for use in parenterally
753753 injecting controlled dangerous substances into the
754754 human body,
755755 k. hypodermic syringes, needles and other objects used,
756756 intended for use, or fashioned specifically for use in
757757 parenterally injecting controlled d angerous substances
758758 into the human body,
759759
760760 Req. No. 6082 Page 16 1
761761 2
762762 3
763763 4
764764 5
765765 6
766766 7
767767 8
768768 9
769769 10
770770 11
771771 12
772772 13
773773 14
774774 15
775775 16
776776 17
777777 18
778778 19
779779 20
780780 21
781781 22
782782 23
783783 24
784784
785785 l. objects used, intended for use, or fashioned
786786 specifically for use in ingesting, inhaling or
787787 otherwise introducing marijuana, cocaine, hashish or
788788 hashish oil into the human body, such as:
789789 (1) metal, wooden, acryli c, glass, stone, plastic or
790790 ceramic pipes with or without screens, permanent
791791 screens, hashish heads or punctured metal bowls,
792792 (2) water pipes,
793793 (3) carburetion tubes and devices,
794794 (4) smoking and carburetion masks,
795795 (5) roach clips, meaning objects used to ho ld burning
796796 material, such as a marijuana cigarette, that has
797797 become too small or too short to be held in the
798798 hand,
799799 (6) miniature cocaine spoons and cocaine vials,
800800 (7) chamber pipes,
801801 (8) carburetor pipes,
802802 (9) electric pipes,
803803 (10) air-driven pipes,
804804 (11) chillums,
805805 (12) bongs, or
806806 (13) ice pipes or chillers,
807807 m. all hidden or novelty pipes, and
808808
809809 Req. No. 6082 Page 17 1
810810 2
811811 3
812812 4
813813 5
814814 6
815815 7
816816 8
817817 9
818818 10
819819 11
820820 12
821821 13
822822 14
823823 15
824824 16
825825 17
826826 18
827827 19
828828 20
829829 21
830830 22
831831 23
832832 24
833833
834834 n. any pipe that has a tobacco bowl or chamber of less
835835 than one-half (1/2) inch in diameter in which there is
836836 any detectable residue of any controlled dangerous
837837 substance as defined in this section or any other
838838 substances not legal for possession or use;
839839 provided, however, the term "drug paraphernalia" shall not include
840840 separation gins intended for use in preparing tea or spice, clamps
841841 used for constructing electrical equip ment, water pipes designed for
842842 ornamentation in which no detectable amount of an illegal substance
843843 is found or pipes designed and used solely for smoking tobacco,
844844 traditional pipes of an American Indian tribal religious ceremony,
845845 or antique pipes that are thirty (30) years of age or older, or drug
846846 testing strips possessed by a person for purposes of determining the
847847 presence of fentanyl or a fentanyl -related compound;
848848 37. a. "Synthetic controlled substance" means a substance:
849849 (1) the chemical structure of which is substantially
850850 similar to the chemical structure of a controlled
851851 dangerous substance in Schedule I or II,
852852 (2) which has a stimulant, depressant, or
853853 hallucinogenic effect on the cent ral nervous
854854 system that is substantially similar to or
855855 greater than the stimulant, depressant or
856856 hallucinogenic effect on the central nervous
857857
858858 Req. No. 6082 Page 18 1
859859 2
860860 3
861861 4
862862 5
863863 6
864864 7
865865 8
866866 9
867867 10
868868 11
869869 12
870870 13
871871 14
872872 15
873873 16
874874 17
875875 18
876876 19
877877 20
878878 21
879879 22
880880 23
881881 24
882882
883883 system of a controlled dangerous substance in
884884 Schedule I or II, or
885885 (3) with respect to a particular person, which such
886886 person represents or intends to have a stimulant,
887887 depressant, or hallucinogenic effect on the
888888 central nervous system that is substantially
889889 similar to or greater than the stimulant,
890890 depressant, or hallucinogenic effect on the
891891 central nervous system of a controlled dangerous
892892 substance in Schedule I or II.
893893 b. The designation of gamma butyrolactone or any other
894894 chemical as a precursor, pursuant to Section 2-322 of
895895 this title, does not preclude a findin g pursuant to
896896 subparagraph a of this paragraph that the chemical is
897897 a synthetic controlled substance.
898898 c. "Synthetic controlled substance" does not include:
899899 (1) a controlled dangerous substance,
900900 (2) any substance for which there is an approved new
901901 drug application,
902902 (3) with respect to a particular person any
903903 substance, if an exemption is in effect for
904904 investigational use, for that person under the
905905 provisions of Section 505 of the Federal Food,
906906 Drug and Cosmetic Act, Title 21 of the United
907907
908908 Req. No. 6082 Page 19 1
909909 2
910910 3
911911 4
912912 5
913913 6
914914 7
915915 8
916916 9
917917 10
918918 11
919919 12
920920 13
921921 14
922922 15
923923 16
924924 17
925925 18
926926 19
927927 20
928928 21
929929 22
930930 23
931931 24
932932
933933 States Code, Section 355, to the extent conduct
934934 with respect to such subst ance is pursuant to
935935 such exemption, or
936936 (4) any substance to the extent not intended for
937937 human consumption before such an exemption takes
938938 effect with respect to that substance.
939939 d. Prima facie evidence that a substance containing
940940 salvia divinorum has been en hanced, concentrated or
941941 chemically or physically altered shall give rise to a
942942 rebuttable presumption that the substance is a
943943 synthetic controlled substance;
944944 38. "Tetrahydrocannabinols" means all substances that have been
945945 chemically synthesized to emulate the tetrahydrocannabinols of
946946 marijuana, specifically including any tetrahydrocannabinols derived
947947 from industrial hemp;
948948 39. "Isomer" means the optical isomer, except as used in
949949 subsections C and F o f Section 2-204 of this title and paragraph 4
950950 of subsection A of Section 2-206 of this title. As used in
951951 subsections C and F of Section 2-204 of this title, "isomer" means
952952 the optical, positional or geometric isomer. As used in paragraph 4
953953 of subsection A of Section 2-206 of this title, the term "isomer"
954954 means the optical or geometric isomer;
955955 40. "Hazardous materials" means materials, whether solid,
956956 liquid or gas, which are toxic to human, animal, aquatic or plant
957957
958958 Req. No. 6082 Page 20 1
959959 2
960960 3
961961 4
962962 5
963963 6
964964 7
965965 8
966966 9
967967 10
968968 11
969969 12
970970 13
971971 14
972972 15
973973 16
974974 17
975975 18
976976 19
977977 20
978978 21
979979 22
980980 23
981981 24
982982
983983 life, and the disposal of which materia ls is controlled by state or
984984 federal guidelines;
985985 41. "Anhydrous ammonia" means any substance that exhibits
986986 cryogenic evaporative behavior and tests positive for ammonia;
987987 42. "Acute pain" means pain, whether resulting from disease,
988988 accidental or intentional trauma or other cause, that the
989989 practitioner reasonably expects to last only a short period of time.
990990 "Acute pain" does not include chronic pain, pain being treated as
991991 part of cancer care, hospice or other end-of-life care, or pain
992992 being treated as part of palliative care;
993993 43. "Chronic pain" means pain that persists beyond the usual
994994 course of an acute disease or healing of an injury. "Chronic pain"
995995 may or may not be associated with an acute or chronic pathologic
996996 process that causes continuous or intermittent pain over months or
997997 years;
998998 44. "Initial prescription" means a prescription issued to a
999999 patient who:
10001000 a. has never previously been issued a prescription for
10011001 the drug or its pharmaceutical equivalent in the past
10021002 year, or
10031003 b. requires a prescription for the drug or its
10041004 pharmaceutical equivalent due to a surgica l procedure
10051005 or new acute event and has previously had a
10061006
10071007 Req. No. 6082 Page 21 1
10081008 2
10091009 3
10101010 4
10111011 5
10121012 6
10131013 7
10141014 8
10151015 9
10161016 10
10171017 11
10181018 12
10191019 13
10201020 14
10211021 15
10221022 16
10231023 17
10241024 18
10251025 19
10261026 20
10271027 21
10281028 22
10291029 23
10301030 24
10311031
10321032 prescription for the drug or its pharmaceutical
10331033 equivalent within the past year.
10341034 When determining whether a patient was previously issued a
10351035 prescription for a drug or its pharmaceutical equivalent, th e
10361036 practitioner shall consult with the patient and review the medical
10371037 record and prescription monitoring information of the patient;
10381038 45. "Patient-provider agreement" means a written contract or
10391039 agreement that is executed between a practitioner and a patien t,
10401040 prior to the commencement of treatment for chronic pain using an
10411041 opioid drug as a means to:
10421042 a. explain the possible risk of development of physical
10431043 or psychological dependence in the patient and prevent
10441044 the possible development of addiction,
10451045 b. document the understanding of both the practitioner
10461046 and the patient regarding the patient-provider
10471047 agreement of the patient,
10481048 c. establish the rights of the patient in association
10491049 with treatment and the obligations of the patient in
10501050 relation to the responsible use, discontinuation of
10511051 use, and storage of opioid drugs, including any
10521052 restrictions on the refill of prescriptions or the
10531053 acceptance of opioid prescriptions from practitioners,
10541054 d. identify the specific medications and other modes of
10551055 treatment, including physical therapy or exercise,
10561056
10571057 Req. No. 6082 Page 22 1
10581058 2
10591059 3
10601060 4
10611061 5
10621062 6
10631063 7
10641064 8
10651065 9
10661066 10
10671067 11
10681068 12
10691069 13
10701070 14
10711071 15
10721072 16
10731073 17
10741074 18
10751075 19
10761076 20
10771077 21
10781078 22
10791079 23
10801080 24
10811081
10821082 relaxation or psychological counseling, that are
10831083 included as a part of the patient-provider agreement,
10841084 e. specify the measures the practitioner may employ to
10851085 monitor the compliance of the patient including, but
10861086 not limited to, rand om specimen screens and pill
10871087 counts, and
10881088 f. delineate the process for terminating the agreement,
10891089 including the consequences if the practitioner has
10901090 reason to believe that the patient is not complying
10911091 with the terms of the agreement . Compliance with the
10921092 "consent items" shall constitute a valid, informed
10931093 consent for opioid therapy. The practitioner shall be
10941094 held harmless from civil litigation for failure to
10951095 treat pain if the event occurs because of nonadherence
10961096 by the patient with any of the provisions of t he
10971097 patient-provider agreement;
10981098 46. "Serious illness" means a medical illness or physical
10991099 injury or condition that substantially affects quality of life for
11001100 more than a short period of time. "Serious illness" includes, but
11011101 is not limited to, Alzheimer 's disease or related dementias, lung
11021102 disease, cancer, heart failure, renal failure, liver failure or
11031103 chronic, unremitting or intractable pain such as neuropathic pain;
11041104 and
11051105
11061106 Req. No. 6082 Page 23 1
11071107 2
11081108 3
11091109 4
11101110 5
11111111 6
11121112 7
11131113 8
11141114 9
11151115 10
11161116 11
11171117 12
11181118 13
11191119 14
11201120 15
11211121 16
11221122 17
11231123 18
11241124 19
11251125 20
11261126 21
11271127 22
11281128 23
11291129 24
11301130
11311131 47. "Surgical procedure" means a procedure that is performed
11321132 for the purpose of struct urally altering the human body by incision
11331133 or destruction of tissues as part of the practice of medicine. This
11341134 term includes the diagnostic or therapeutic treatment of conditions
11351135 or disease processes by use of instruments such as lasers,
11361136 ultrasound, ionizing, radiation, scalpels, probes or needles that
11371137 cause localized alteration or transportation of live human tissue by
11381138 cutting, burning, vaporizing, freezing, suturing, probing or
11391139 manipulating by closed reduction for major dislocations or
11401140 fractures, or otherwise altering by any mechanical, thermal, light-
11411141 based, electromagnetic or chemical means.
11421142 SECTION 2. This act shall become effective November 1, 2023.
11431143
11441144 59-1-6082 GRS 12/20/22